In vitro Notch-mediated adjuvant immunogenic potency is induced by combining QS-21 and MPL in a co-culture model of PBMC and HUVEC cells
lentivectors
Few vaccine adjuvants have been authorised for human use though a number of are at the moment being studied in preclinical and scientific trial. MPL is a toll-like receptor agonist in a position to set…Continue Reading